Abstract
The purpose of this chapter is not to give a comprehensive overview of all aspects of fat and carbohydrate metabolism but to focus on glucose intolerance, its possible causes and the possible relationship with changes in fat metabolism. Facts with regard to metabolic disorders in liver disease are accumulating rapidly but the mechanisms involved are far from understood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
C. M. Leevy, C. M. Ryan, and J. C. Fineberg, Diabetes mellitus and liver dysfunction: etiologic and therapeutic considerations, Am. J. Med. 8: 290 (1950).
P. K. Bondy, Some metabolic anormalities in liver disease, Am. J. Med. 24: 428 (1958).
R. Hed, Clinical studies in chronic alcoholism. I. Incidence of diabetes mellitus in portal cirrhosis, Acta Med. Scand. 162: 189 (1958).
J. P. Felber, P. Magnenat, and A. Vannotti, Tolérance au glucose diminuée et réponse insulinique élevée dans la cirrhose, Schweiz. Med. Wschr 97: 1537 (1967).
J. R. Collins and O. B. Crofford, Glucose intolerance and insulin resistance in patients with liver disease, Arch. Int. Med. 124: 142 (1969).
J. Marco, J. Diego, M. L. Villanueva, M. Diaz-Fierros, I. Valverde, and J. M. Segovia, Elevated plasma glucagon levels in cirrhosis of the liver, New Engl. J. Med. 89: 1107 (1973).
R. Sherwin, P. Joshi, R. Hendler, Hyperglucagonemia in Laennec’s cirrhosis. The role of portal-systemic shunting, New Engl. J. Med. 290: 239 (1974).
R. S. Sherwin, M. Fisher, J. Bessoff, N. Snyder, R. Hendler, H. O. Conn,and P. Felig, Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon, Gastroenterology 74: 1224 (1978).
A. Mortiaux and A. M. Dawson, Plasma free fatty acid in liver disease, Gut 2: 304 (1961).
K. G. M. M. Alberti and D. G. Johnston, Carbohydrate Metabolism in Liver Disease in:“Liver and Biliary Disease, Pathophysiology, Diagnosis, Management” R. Wright, ed., W. B. Saunders Company Ltd., London, Philadelphia, Toronto (1979).
H. Ring-Larsen, B. Hesse, J. H. Henriksen,and N. J. Christensen, Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: Plasma norepinephrine concentration, hepatic extraction and renal release Hepatology 2: 304 (1982).
O. Riggio, M. Merli, C. Cangiano, R. Capocaccia, A. Cascino, A. Lala, F. Leonetti, M. Mauceri, M. Pepe, F. Rossi-Fanelli, M. Savioli, G. Tamburrano,and L. Capocaccia, Glucose intolerance in liver cirrhosis, Metabolism 31: 627 (1982).
R. S. Sherwin, Effect of epinephrine on fuel metabolism in man: Role in the response to stress. Proceedings of the 4th Espen Congress, Vienna. In press (1982).
P. R. Black, D. C. Brooks, P. Q. Bessey, R. R. Wolfe, and D. W. Wilmore, Mechanisms of insulin resistance following injury, Ann. Surg. 196: 420 (1982).
D. C. Deibert and R. A. DeFronzo, Epinephrine-induced insulin resistance in man, J. Clin. Invest. 65: 717 (1980).
J. E. Liljenquist and D. Rabin, Lack of a role for glucagon in the disposal of an oral glucose load in normal man, J. Clin. Endocrinol. Metab. 49: 937 (1979).
R. H. Unger and L. Orci, Role of glucagon in diabetes, Arch. Int. Med. 137: 482 (1977).
H. N. Munro, D. Fernstrom,and R. J. Wurtman, Insulin, plasma amino acid imbalance and hepatic coma, Lancet 1: 722 (1975).
C. O. Record, R. A. Chase, K. G. M. M. Alberti,and R. Williams, Disturbances in glucose metabolism in patients with liver damage due to paracetamol overdose, Clin. Sci. Mol. Med. 49: 473 (1975).
K. G. M. M. Alberti, C. O. Record, D. H. Williamson, and R. Wright, Metabolic changes in active chronic hepatitis, Clin. Sci. Mol. Med. 42: 591 (1972).
P. B. Soeters, G. Weir, A. M. Ebeid, and J. E. Fischer, Insulin, glucagon, portal systemic shunting and hepatic failure in the dog, J. Surg. Res. 23: 183 (1977).
P. Rous and L. D. Larimore, Relation of the portal blood to liver maintenance: A demonstration of liver atrophy condition on compensation, J. Exp. Med. 31: 600 (1920).
T. E. Starzi, K. Watanabe, and K. A. Porter, Effect of insulin, glucagon and insulin/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs, Lancet 1: 821 (1976).
H. O. Conn, Ammonia tolerance as an index of portal-systemic collateral circulation in cirrhosis, Gastroenterology 41: 97 (1961).
A. R. Burchell, A. H. Moreno, W. F. Panke, and T. F. Nealon, Hepatic artery flow improvement after portacaval shunt: a single haemodynamic clinical correlate, Ann. Surg. 184: 289 (1976).
P. J. Lefebvre and A. S. Luyckx, Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog, Metabolism 24: 1169 (1975).
S. C. Woods and D. Porte, Jr., Neural control of the endocrine pancreas, Physiol. Rev. 54: 596 (1974).
L. Orci, A portrait of the pancreatic beta cell, Diabetologia 10: 163 (1974).
J. P. Palmer, D. P. Henry, J. W. Benson, D. G. Johnson, and J. W. Ensinck, Glucagon response to hypoglycemia in sympatectomized man, J. Clin. Invest. 57: 522 (1976).
J. Iversen, Adrenergic receptors and the secretion of glucagon and insulin from the isolated perfused canine pancreas., J. Clin. Invest. 52: 2102 (1973).
J. E. Gerich, J. H. Karam, and P. H. Forsham, Stimulation of glucagon secretion by epinephrine in man, J. Clin. Endocrin. Metab. 37: 479 (1973).
J. E. Gerich, M. Langlois, C. Noacco, V. Schneider, and P. H. Forsham, Adrenergic modulation of pancreatic glucagon secretion in man, J. Clin. Invest. 53: 1441 (1974).
E. J. Rayfield, D. T. George, H. L. Eichner, and T. H. Tsu, L-Dopa stimulation of glucagon secretion in man, New Engl. J. Med. 293: 589 (1975).
J. W. Ensinck, R. M. Walter, J. P. Palmer, R. G. Brodows, and R. G. Campbell, Glucagon responses to hypoglycemia in Adrenalectomized Man, Metabolism 25: 227 (1976).
J. P. Palmer, J. Halter, and P. L. Werner, Differential effect of isoproterenol on acute glucagon and insulin release in man, Metabolism 28: 237 (1979).
A. S. Luyckx and P. J. Lefebvre, Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids, Proc. Soc. Exp. Biol. Med. 133: 524 (1970).
S. S. Andrews, S. A. Lopez, and W. G. Blackard, Effect of lipids on glucagon secretion in man, Metabolism 24: 35 (1975).
J. K. Wise, R. Hendler, and P. Felig, Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man, J. Clin. Invest. 52: 2774 (1973).
E. Holm, Personal communication.
M. R. Lunzer, S. P. Newman, A. G. Bernard, K. K. Manghani, S. P. V. Sherlock, and J. Ginsburg, Impaired cardiovascular responsiveness in liver disease, Lancet 2: 382 (1975).
D. G. Johnston, K. G. M. M. Alberti, O. K. Faber, and C. Binder, Hyperinsulinism of hepatic cirrhosis: diminished degradation or hypersecretion? Lancet, January 1: 10 (1977).
D. G. Johnston, K. G. M. M. Alberti, R. Wright, G. Smith-Laing, A. M. Stewart, S. Sherlock, O. Faber,and C. Binder, C-peptide and insulin in liver disease, Diabetes 27 (Suppl. 1): 201 (1978).
G. Smith-Laing, S. Sherlock, and O. K. Faber, Effects of spontaneous portal-systemic shunting on insulin metabolism, Gastroenterology 76: 685 (1979).
A. I. Katz and A. H. Rubenstein, Metabolism of pro-insulin, insulin and C-peptide in the rat, J. Clin. Invest. 52: 1113 (1973).
R. W. Stoll, J. L. Touber, L. A. Menahan, and R. H. Williams, Clearance of porcine, insulin, pro-insulin and connecting peptides by the isolated rat liver, Proc. Soc. Exp. Biol. Med. 133: 894 (1970).
C. Kúhl, O. K. Faber, P. Hornnes, and S. Jensen Lindkaer, Cpeptide metabolism and the liver, Diabetes 27 (Suppl. 1): 197 (1978).
G. Oehler, H. Bleyl,and K. J. Matthes, Glucose tolerance and serum insulin in different chronic liver diseases. VI International Congress of Liver Diseases, Basel, October 15–17, Abstract no. 145 (1982).
P. Vannini, G. Forlani, G. Marchesini, and E. Pisi, Evaluation of insulin resistance in liver cirrhosis by means of the glucose clamp technique, Ital. J. Gastroenterol. 13: 255 (1981).
R. Taylor, R. Heine, J. Collins, K. G. M. Alberti, and O. F. W. James, No marked impairment of insulin binding to adipocytes in insulin resistant cirrhotics. VI International Congress of Liver Diseases. Basel, October 15–17, 1982. Abstract no. 193 (1982).
P. J. Randle, C. N. Hales, P. B. Garland, and E. A. Newsholme, The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus, Lancet 1: 7285 (1963).
E. A. Newsholme and C. Start, Regulation of fat metabolism in liver. Introduction. in:“Regulation in Metabolism;’ Chapter 7. John Wiley, London, New York, Toronto (1974).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Soeters, P.B., de Boer, J.E.G., Oostenbroek, R.J., Janssen, M.A. (1984). Carbohydrate Metabolism in Liver Disease. In: Capocaccia, L., Fischer, J.E., Rossi-Fanelli, F. (eds) Hepatic Encephalopathy in Chronic Liver Failure. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4787-3_15
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4787-3_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4789-7
Online ISBN: 978-1-4684-4787-3
eBook Packages: Springer Book Archive